WEDNESDAY, Sept. 18, 2024 -- Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients,...
Vous n'êtes pas connecté
FRIDAY, Sept. 27, 2024 -- Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression, according to a study presented at the annual meeting of the American Neurological Association, held Sept...
WEDNESDAY, Sept. 18, 2024 -- Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients,...
FRIDAY, Sept. 27, 2024 -- Vaping is tied to lower cognitive scores in college students, according to a study presented at the annual meeting of the...
New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...
THURSDAY, Sept. 26, 2024 -- For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does...
A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and reduced use of crucial...
MONDAY, Sept. 23, 2024 -- For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes,...
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal...
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal...
A groundbreaking study has identified key biomarkers that predict disability progression in multiple sclerosis (MS). This discovery could...
Discover how identifying biomarkers can help to predict disability progression in multiple sclerosis (MS).